Delta Air Lines became the first title sponsor of the 2015 Marianas March Against Cancer after donating passenger tickets and travel vouchers last Friday at Delta’s check-in area inside the Francisco C. Ada International Airport
Chris Concepcion, Delta sales account executive, presented the in-kind donation that included one main cabin ticket to anywhere in the United States, one main cabin ticket to Japan, and $600 worth of travel vouchers.
Delta is now a title sponsor, the topmost level sponsorship, which goes to a sponsor that donates $3,000 or more in cash or in-kind.
“Delta is pleased to be named the first confirmed title sponsor of the 2015 MMAC. We are thrilled to continue our support of the MMAC and the Commonwealth Cancer Association in their efforts to spread cancer awareness in our community,” Concepcion said.
“They also provide support for those currently battling this dreadful disease so we hope our donation will help raise badly needed funds for the fight against cancer. We encourage the community to come out and support all 2015 MMAC teams on May 1-2,” he added.
MMAC overall committee chair Diana I. Benavente was very grateful for the donation.
“We truly appreciate Delta for their donation because the raffle tickets that we sell is usually the first to run out and everybody really wants that chance to have that ticket and travel vouchers. We’re really excited that Delta has supported us again this year and we’re glad also that they are our title sponsors,” Benavente said.
Businesses, individuals, and organizations that also wish to support the 2015 MMAC may donate funds, services, or raffle items. Sponsorship levels include title sponsor (donating $3,000 or more), major sponsor (donating $1,000 to $2,999), or supporting sponsorship (donating $1 to $999).
This year’s event will be held at the Hopwood Junior High School field from May 1 to 2. Money raised from MMAC is used by CCA to promote cancer awareness and prevention, provide patient support services, and serve as the liaison and advocate for cancer issues in the CNMI.